Showing results (751-760 of 1,135) with videos related to
Sort By:
Pageof 114
Journal of Virology|May 1, 1989
Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolatesM Tersmette, R A Gruters, F de Wolf, et al.International Journal of Food Microbiology|April 6, 2002
Modelling microbial growth in structured foods: towards a unified approachP D G Wilson, T F Brocklehurst, S Arino, et al.Prostate Cancer and Prostatic Diseases|October 26, 2005
Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American menJ L Beebe-Dimmer, L A Lange, J E Cain, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 18, 2003
Pharmacokinetics of once-daily saquinavir hard-gelatin capsules and saquinavir soft-gelatin capsules boosted with ritonavir in HIV-1-infected subjectsPeter G Cardiello, Tarkika Monhaphol, Apicha Mahanontharit, et al.The Journal of Infectious Diseases|June 1, 2007
Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudyRaaj R Sankatsing, Ferdinand W Wit, Nadine Pakker, et al.Frontiers in Immunology|May 1, 2018
Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty AcidsChengcong Cai, Benjamin Koch, Kenichi Morikawa, et al.Langenbeck'S Archives of Surgery|May 12, 2023
Regional transplant rates depend more on physician-dependent variables than on proximity to transplant centerElnaz Payani, Nikolaus Börner, Dionysios Kolliogiannis, et al.Cancer Research|July 4, 2003
Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American menDavid C Miller, S Lilly Zheng, Rodney L Dunn, et al.Journal of Virology|September 1, 1996
Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative GroupB A Larder, A Kohli, S Bloor, et al.AIDS (London, England)|April 1, 1993
Antigenic variation of the dominant gp41 epitope in AfricaJ M Lange, V J Teeuwsen, C A Boucher, et al.Pageof 114